{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:15:09Z","timestamp":1788225309857,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinre.2026.102849","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:59:40Z","timestamp":1779173980000},"page":"102849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing approach to liver biochemistry abnormalities in cystic fibrosis pediatrics: Balancing efficiency and risk-benefit"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-0162","authenticated-orcid":false,"given":"Sarah B.","family":"Lowry Adamitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wikrom","family":"Karnsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0001","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jcf.2024.12.010","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on liver transient elastography, fibrosis indices and blood tests in children with cystic fibrosis","volume":"24","author":"Terlizzi","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"21","key":"10.1016\/j.clinre.2026.102849_bib0002","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0003","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2016.08.002","article-title":"Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen","volume":"16","author":"Woodruff","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.clinre.2026.102849_bib0004","first-page":"54","article-title":"Cystic fibrosis liver disease in the new era of cystic fibrosis transmembrane conductance regulator (CFTR) modulators","volume":"50","author":"Eldredge","year":"2024","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0005","first-page":"69","article-title":"Liver disease in cystic fibrosis","volume":"15","author":"Leeuwen","year":"2014","journal-title":"Paediatr Respir Rev"},{"issue":"6","key":"10.1016\/j.clinre.2026.102849_bib0006","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/MCP.0000000000001017","article-title":"Cystic fibrosis liver disease in the post-modulator era","volume":"29","author":"Narkewicz","year":"2023","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"10.1016\/j.clinre.2026.102849_bib0007","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ppul.26970","article-title":"SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; proceedings of the international shaping initiatives and future trends (SHIFT) Symposium","volume":"59","author":"O'Donnell","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102849_bib0008","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10620-024-08784-0","article-title":"Integration of non-invasive screening for cystic fibrosis related liver disease in the regular follow-up for cystic fibrosis","volume":"70","author":"Coman","year":"2025","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0009","article-title":"Determination of reference intervals for common liver function tests among healthy adults","volume":"15","author":"Abbas","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.clinre.2026.102849_bib0010","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2026.102849_bib0011","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","article-title":"Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.gastro.2014.05.027","article-title":"Drug-induced liver injury: morbidity, mortality, and Hy's law","volume":"147","author":"Regev","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinre.2026.102849_bib0013","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1542\/neo.14-2-e63","article-title":"Neonatal cholestasis","volume":"14","author":"Feldman","year":"2013","journal-title":"Neoreviews"},{"issue":"11","key":"10.1016\/j.clinre.2026.102849_bib0014","first-page":"873","article-title":"Evaluation and treatment of neonatal hyperbilirubinemia","volume":"89","author":"Muchowski","year":"2014","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.clinre.2026.102849_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10408363.2018.1428526","article-title":"Diagnostic criteria and contributors to Gilbert's syndrome","volume":"55","author":"Wagner","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"6","key":"10.1016\/j.clinre.2026.102849_bib0016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000369205","article-title":"Alkaline phosphatase in healthy children: reference intervals and prevalence of elevated levels","volume":"82","author":"Ridefelt","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.clinre.2026.102849_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.09.2009.2250","article-title":"Transient rise in alkaline phosphatase activity in adults","volume":"2009","author":"Jassam","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.clinre.2026.102849_bib0018","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00431-023-04825-4","article-title":"Incidental hypertransaminasemia in children: a stepwise approach in primary care","volume":"182","author":"Costa","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cld.2014.09.010","article-title":"Liver disease in the adolescent","volume":"19","author":"Mavis","year":"2015","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clinre.2014.02.010","article-title":"A practical approach to the child with abnormal liver tests","volume":"38","author":"Lamireau","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"47","key":"10.1016\/j.clinre.2026.102849_bib0021","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e310","article-title":"A multicenter study of real-world practice for management of abnormal liver function tests in children with acute infectious diseases","volume":"36","author":"Lee","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"11","key":"10.1016\/j.clinre.2026.102849_bib0022","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3346\/jkms.2016.31.11.1784","article-title":"Distribution of diseases causing liver function test abnormality in children and natural recovery time of the abnormal liver function","volume":"31","author":"Jang","year":"2016","journal-title":"J Korean Med Sci"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005792-199201000-00002","article-title":"Relapsing hepatitis A: review of 14 cases and literature survey","volume":"71","author":"Glikson","year":"1992","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.clinre.2026.102849_bib0024","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/imj.12707","article-title":"Idiosyncratic reactions are the most common cause of abnormal liver function tests in patients with cystic fibrosis","volume":"45","author":"Jong","year":"2015","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijms17010014","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clinre.2026.102849_bib0026","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jpn3.12167","article-title":"Measurement practices of alanine aminotransferase in children: temporal changes and etiology for increased values","volume":"78","author":"Aitokari","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0027","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s10620-024-08730-0","article-title":"Unexplained chronically elevated aminotransferases: liver biopsy gives major information with therapeutic implication in one patient out of seven","volume":"70","author":"Pietri","year":"2025","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.clinre.2026.102849_bib0028","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s40264-013-0045-7","article-title":"Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries","volume":"36","author":"Ferrajolo","year":"2013","journal-title":"Drug Saf"},{"issue":"11","key":"10.1016\/j.clinre.2026.102849_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166683","article-title":"Transient elastography-based liver stiffness age-dependently increases in children","volume":"11","author":"Tokuhara","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0030","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apa.15469","article-title":"Prevalence of elevated liver enzymes and comorbidities in children and adolescents with overweight and obesity","volume":"110","author":"Hartman","year":"2021","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0031","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"4","key":"10.1016\/j.clinre.2026.102849_bib0032","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jpn3.12460","article-title":"The change of alanine aminotransferase distributions among US youths, NHANES 1988-2020","volume":"80","author":"Mallhi","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0033","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15386\/mpr-2806","article-title":"Impact of CFTR modulatory therapies on liver function and fibrosis indices in cystic fibrosis patients: a retrospective analysis from two Romanian medical centers","volume":"98","author":"Moiceanu","year":"2025","journal-title":"Med Pharm Rep"},{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0034","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/LVT.0000000000000529","article-title":"Have CFTR modulators changed the need for liver and lung transplantation among patients with cystic fibrosis? An analysis of the UNOS database","volume":"31","author":"Mendizabal","year":"2025","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.clinre.2026.102849_bib0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2016.09.017","article-title":"Extensive testing or focused testing of patients with elevated liver enzymes","volume":"66","author":"Tapper","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102849_bib0036","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jcf.2020.05.002","article-title":"A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease","volume":"19","author":"Karnsakul","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0037","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MPG.0000000000002413","article-title":"Liver ultrasound patterns in children with cystic fibrosis correlate with noninvasive tests of liver disease","volume":"69","author":"Ling","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2026.102849_bib0038","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpeds.2019.12.033","article-title":"Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease: interim results of a prospective observational case-controlled study","volume":"219","author":"Siegel","year":"2020","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.clinre.2026.102849_bib0039","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jpeds.2015.06.062","article-title":"Baseline ultrasound and clinical correlates in children with cystic fibrosis","volume":"167","author":"Leung","year":"2015","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.clinre.2026.102849_bib0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2022.07.017","article-title":"Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study","volume":"22","author":"Leung","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.clinre.2026.102849_bib0041","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/hep4.1719","article-title":"Association between transient elastography and controlled attenuated parameter and liver ultrasound in children with cystic fibrosis","volume":"5","author":"Ye","year":"2021","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.clinre.2026.102849_bib0042","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00365521.2020.1786599","article-title":"Biomarkers of liver fibrosis: prospective comparison of multimodal magnetic resonance, serum algorithms and transient elastography","volume":"55","author":"Forsgren","year":"2020","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.clinre.2026.102849_bib0043","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00247-023-05706-6","article-title":"Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound","volume":"53","author":"Towbin","year":"2023","journal-title":"Pediatr Radiol"},{"issue":"10","key":"10.1016\/j.clinre.2026.102849_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MEG.0b013e328360762e","article-title":"The utility of magnetic resonance cholangiopancreatography for the assessment of patients with elevated liver enzyme levels","volume":"25","author":"Benjaminov","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2026.102849_bib0045","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.28016","article-title":"Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease","volume":"62","author":"Leung","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0046","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.japh.2023.02.015","article-title":"Incidence of transaminitis in adults with cystic fibrosis taking elexacaftor\/tezacaftor\/ivacaftor","volume":"63","author":"Wood","year":"2023","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68511-7","article-title":"Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del\/CFTR variant genotype after elexacaftor\/tezacaftor\/ivacaftor treatment","volume":"14","author":"Castaldo","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clinre.2026.102849_bib0048","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2023.01.005","article-title":"Drug-drug interactions with CFTR modulator therapy in cystic fibrosis: focus on Trikafta\u00ae\/Kaftrio\u00ae","volume":"22","author":"Purkayastha","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.clinre.2026.102849_bib0049","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clinre.2026.102849_bib0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"11","key":"10.1016\/j.clinre.2026.102849_bib0051","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/liv.15748","article-title":"The non-invasive evaluation of liver involvement in patients with cystic fibrosis: a prospective study","volume":"43","author":"Dajti","year":"2023","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clinre.2026.102849_bib0052","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MPG.0000000000001728","article-title":"Variceal hemorrhage and adverse liver outcomes in patients with cystic fibrosis cirrhosis","volume":"66","author":"Ye","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:46:20Z","timestamp":1788223580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2210740126000951"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102849","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing approach to liver biochemistry abnormalities in cystic fibrosis pediatrics: Balancing efficiency and risk-benefit","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102849"}}